The iboga enigma: The chemistry and neuropharmacology of iboga alkaloids and related analogs

Rishab N. Iyer, David Favela, Guoliang Zhang, David E. Olson

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Covering: 2000 up to 2020 Few classes of natural products have inspired as many chemists and biologists as have the iboga alkaloids. This family of monoterpenoid indole alkaloids includes the anti-addictive compound ibogaine as well as catharanthine, a precursor to the chemotherapeutic vinblastine. Despite being known for over 120 years, these small molecules continue to challenge our assumptions about biosynthetic pathways, catalyze our creativity for constructing complex architectures, and embolden new approaches for treating mental illness. This review will cover recent advances in both the biosynthesis and chemical synthesis of iboga alkaloids as well as their use as next-generation neurotherapeutics. Whenever appropriate, we provide historical context for the discoveries of the past decade and indicate areas that have yet to be resolved. While significant progress regarding their chemistry and pharmacology has been made since the 1960s, it is clear that the iboga alkaloids will continue to stoke scientific innovation for years to come. This journal is

Original languageEnglish (US)
Pages (from-to)307-329
Number of pages23
JournalNatural Product Reports
Volume38
Issue number2
DOIs
StatePublished - Feb 2021

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'The iboga enigma: The chemistry and neuropharmacology of iboga alkaloids and related analogs'. Together they form a unique fingerprint.

Cite this